Enhua Pharmaceutical: In the first half of 2026, net profit reached 741 million yuan, a year-on-year increase of 5.74%.

Enhua Pharmaceutical announced that in the first half of 2026, the operating revenue was 3.218 billion yuan, a year-on-year increase of 6.91%; the net profit attributable to shareholders of the listed company was 741 million yuan, a year-on-year increase of 5.74%; the net profit attributable to shareholders of the listed company, after deducting non-recurring gains and losses, was 746 million yuan, a year-on-year increase of 6.65%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert capital reserves into share capital.